Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Serotonin Antagonists

Known as: Blockers, Serotonin Receptor, Antagonists, 5 HT, Antagonists, Serotonin 
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS.
National Institutes of Health

Related topics

Related topics

48 relations

Narrower (42)

6-nitroquipazineBufoteninClozapineCyproheptadine
Expand
Decarboxylase inhibitorIn BloodSerotoninantagonistic drug interaction
Expand

Broader (1)

Pharmaceutical Preparations

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Sudden unexpected death in epilepsy: Risk factors, biomarkers, and prevention
Sudden unexpected death in epilepsy (SUDEP) is one of the most important direct epilepsy‐related causes of death, with an… Expand
Review
2018
Review
2018
Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review
Randomized trials have shown that selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Review
2018
Review
2018
EP4 as a Therapeutic Target for Aggressive Human Breast Cancer
G-protein-coupled receptors (GPCRs, also called seven-transmembrane or heptahelical receptors) are a superfamily of cell surface… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2018
Review
2018
Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials
Summary Background Gastroprotectant drugs are used for the prevention and treatment of peptic ulcer disease and might reduce its… Expand
Review
2017
Review
2017
Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis.
In patients with gastroesophageal reflux disease (GERD) and erosive esophagitis, treatment with proton pump inhibitors (PPIs) is… Expand
  • figure 1
  • table 2
  • figure 2
  • figure 3
Highly Cited
2011
Highly Cited
2011
Eplerenone in patients with systolic heart failure and mild symptoms.
BACKGROUND Mineralocorticoid antagonists improve survival among patients with chronic, severe systolic heart failure and heart… Expand
  • table 1
  • table 1
  • figure 1
  • table 2
  • table 3
Highly Cited
2006
Highly Cited
2006
Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.
BACKGROUND Persistent pulmonary hypertension of the newborn (PPHN) is associated with substantial infant mortality and morbidity… Expand
  • table 1
  • table 1
  • table 2
Highly Cited
1990
Highly Cited
1990
Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum.
Amphetamine and cocaine are stimulant drugs that act on central monoaminergic neurons to produce both acute psychomotor… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
1976
Highly Cited
1976
Synaptic facilitation and behavioral sensitization in Aplysia: possible role of serotonin and cyclic AMP.
The neural changes accompanying sensitization of the gill-withdrawal reflex in Aplysia are associated with presynaptic… Expand
Highly Cited
1974
Highly Cited
1974
Muscarinic cholinergic binding in rat brain.
Binding sites with high affinity and specificity for [(3)H]quinuclidinyl benzilate (QNB) are present in homogenates of rat brain… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE